Brief: Kiniksa Pharmaceuticals Unit Enters Master Services Agreement And Product Specific Agreement With Samsung Biologics

Kiniksa Pharmaceuticals International

25/06/2024 21:41

June 25 (Reuters) - Samsung Biologics Co Ltd
 207940.KS :
    * KINIKSA PHARMACEUTICALS LTD - UNIT ENTERED MASTER SERVICES
AGREEMENT AND PRODUCT SPECIFIC AGREEMENT WITH SAMSUNG BIOLOGICS
CO., LTD.
    * KINIKSA PHARMACEUTICALS - SAMSUNG TO PERFORM TECH.
TRANSFER,
PROCESS PERFORMANCE QUALIFICATION, MANUFACTURING & SUPPLY
SERVICES FOR SUPPLY OF ARCALYST

Source text for Eikon:  ID:n0001104659-24-074763 
Further company coverage:  207940.KS 

 ((reuters.briefs@thomsonreuters.com;))